Page 5 - Nasdaq Ango News Today

AngioDynamics (NASDAQ:ANGO – Get Rating) and Beauty Health (NASDAQ:SKIN – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, analyst recommendations, earnings, risk and institutional ownership. Earnings and Valuation This table compares AngioDynamics and Beauty Health’s […]

SG Americas Securities LLC decreased its holdings in AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) by 45.5% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 13,606 shares of the medical instruments supplier’s stock after selling 11,354 shares during the period. SG Americas Securities LLC’s holdings […]

Equities analysts expect that AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) will report sales of $82.62 million for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for AngioDynamics’ earnings, with the highest sales estimate coming in at $84.20 million and the lowest estimate coming in at $81.80 million. AngioDynamics posted sales of $76.84 […]

Brokerages forecast that AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) will report earnings of $0.01 per share for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for AngioDynamics’ earnings. The lowest EPS estimate is $0.00 and the highest is $0.01. The firm is scheduled to announce its next quarterly earnings results […]

Equities analysts expect AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) to post earnings per share (EPS) of $0.01 for the current quarter, according to Zacks. Three analysts have provided estimates for AngioDynamics’ earnings, with estimates ranging from $0.00 to $0.01. The company is scheduled to issue its next earnings report on Monday, January 1st. According to […]

AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) has been given a consensus rating of “Hold” by the seven brokerages that are presently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, two have given a hold rating, one has given a buy rating and one has assigned a strong […]

Equities analysts forecast that AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) will announce $0.01 earnings per share for the current quarter, Zacks Investment Research reports. Three analysts have provided estimates for AngioDynamics’ earnings, with the highest EPS estimate coming in at $0.01 and the lowest estimate coming in at $0.00. The business is scheduled to announce […]

AngioDynamics (NASDAQ:ANGO – Get Rating) updated its FY 2022 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $-0.020-$0.020 for the period, compared to the Thomson Reuters consensus estimate of $-0.010. The company issued revenue guidance of $310 million-$315 million, compared to the consensus revenue estimate of $313.65 million. ANGO has […]

AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) – Stock analysts at Oppenheimer lowered their Q4 2022 earnings per share (EPS) estimates for shares of AngioDynamics in a research note issued to investors on Friday, April 8th. Oppenheimer analyst S. Lichtman now expects that the medical instruments supplier will post earnings per share of $0.01 for the […]

Equities analysts expect that AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) will post sales of $81.81 million for the current fiscal quarter, according to Zacks. Three analysts have made estimates for AngioDynamics’ earnings. The lowest sales estimate is $81.60 million and the highest is $82.00 million. AngioDynamics reported sales of $76.84 million in the same quarter […]